Dose‐Adjusted EPOCH‐R and Mid‐Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement
Dai Chihara; Nathan H. Fowler; Yasuhiro Oki; Michelle A. Fanale; Luis E. Fayad; Jason R. Westin; Fredrick B. Hagemeister
Author Information: Department of Lymphoma/Myeloma
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.